Contact the Editorial Desk

Editorial correspondence

Auroa Peptides welcomes correspondence about the research record: a citation quoted inaccurately, a regulatory reference that has since changed, or a peer-reviewed study on GHK-Cu, BPC-157, TB-500 or the GLOW combination that merits inclusion in the references list. Corrections that sharpen the accuracy of the digest are the most useful messages we receive, and they are read carefully.

The most actionable notes are specific: they name the page, the exact passage in question, and a supporting DOI or PubMed ID. That lets us verify a proposed change against the source directly.

Editorial mailbox: editors@auroapeptides.com

What this desk cannot do

So that no message goes unanswered for the wrong reason, a few things are outside what this site can address. Auroa Peptides is a literature digest, not a clinic or a vendor, so we cannot:

• Advise on, recommend, or comment on human use of any compound discussed here.
• Suggest a dose, schedule, or route of administration for any individual.
• Diagnose a condition or evaluate whether a research finding applies to a particular person.
• Sell, source, recommend, or help locate any compound from any supplier or clinic.
• Answer requests from athletes subject to anti-doping rules about the GLOW blend or its constituents, given that two of its three peptides are prohibited by WADA.

Readers seeking medical or cosmetic guidance should consult a licensed clinician in their own jurisdiction. Editorial correspondence is monitored intermittently; responses are not guaranteed.